Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)

Author： Coca Antonio  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.28, Iss.4, 2008-01, pp. : 211-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II receptor blockers for the treatment of hypertension

By See Sharon  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. : 1795-1804

Informa Healthcare

Access to resources Recommend Favorite

Risk-benefit assessment of angiotensin II receptor antagonists

By Shusterman Neil  

Expert Opinion on Drug Safety, Vol. 1, Iss. 2, 2002-07 ,pp. : 137-152

Informa Healthcare

Access to resources Recommend Favorite

Vascular benefits of angiotensin receptor blockers

By Voors   Adriaan A  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet

By Boesen Erika I.   Pollock Jennifer S.   Pollock David M.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 8, 2010-08 ,pp. : 802-807

NRC Research Press

Access to resources Recommend Favorite

Angiotensin II receptor antagonists -

By Burnier M.   Brunner H.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite